Nanoparticles initially designed as biological markers are entering their first therapeutic trial as a treatment for patients with advanced, recurrent or refractory cancers.
The technology has been refined and improved since its unveiling in 2005. C’Dots have been used to create the world’s smallest laser and have shown the diagnostic ability to find tumors; a new version was armed with nano-sized antibody fragments; and in separate studies actually induced, without attaching a drug, a form of cell death in tumors.
Now C’Dots, proven safe and effective in three previous diagnostic human clinical trials, have just begun their first therapeutic trial.
After being further developed by Elucida Oncology, Inc., a New Jersey-based biotechnology company co-founded by Wiesner, the newest iteration of C’Dots is referred to as CDCs—C’Dot drug conjgates—a nanoparticle with dozens of drug molecules attached.
One key to C’Dots is their ability to be efficiently cleared from the body via the kidneys with minimal off-target accumulation.
“We have this [trademarked] ‘Target or Clear’ paradigm,” Wiesner said. “They either target the tumor, or they get out and do not accumulate at off-target sites in your body. Therefore, they are expected to substantially reduce side effects, relative to previous [therapeutic] platforms.”
Elucida’s technology features a 10-step process in which C’Dots either find their mark or are eliminated. After injection and circulation in the bloodstream, the CDCs find the tumor. CDCs then diffuse through the tumor microenvironment to specifically target tumor cells.
This is key: The better CDCs diffuse through the entirety of the tumor, the better they can target cells throughout the tumor, and not just those on the surface layer.
“Target or Clear” leads to efficient biodistribution; accumulation in the tumor is maximized, while off-target accumulation (in the liver, for example) is minimized, reducing the potential for negative side effects such as those often suffered by chemotherapy patients.
Despite their ultra-small size, C’Dots can be armed with a payload of up to 80 molecules of synthetic drugs without compromising the desired targeting and pharmacokinetic properties.
In an article published in the journal Science of the Total Environment, researchers have highlighted the significance and potential risks associated with the release of nanoparticles from coal-fired power plants. Applying the single-particle inductively coupled plasma mass [...]
A paper recently published in the journal ACS Applied Energy Materials demonstrated the feasibility of using a covalent organic framework (COF)-based nanofluidic hybrid membranes (NHMs) to attain enhanced interfacial ion transport for the generation of osmotic [...]
The excess fluoroquinolones (FQs) discharged into the aquatic environment due to human activities must be removed cost-effectively. In an article published in the Journal of Cleaner Production, the authors fabricated an environment-friendly dealkaline lignin-grafted Fe3O4 nanoparticles [...]
Controlling strong electromagnetic fields on nanoparticles is the key to triggering targeted molecular reactions on their surfaces. Such control over strong fields is achieved via laser light. Although laser-induced formation and breaking of molecular [...]
A paper recently published in the journal Nature Communications demonstrated an effective method to realize on-chip nanophotonic topological rainbow devices using the concept of synthetic dimensions. Importance of Synthetic Dimensions for the Construction of Topological Nanophotonics [...]
In a study available in the journal Materials Today: Proceedings, silver nanoparticles (Ag NPs) were fabricated using a green method using Citrus X sinensis. Methylthioninium Chloride (MB) Dyes Threatening the Environment Dye and sewage drainage into [...]
Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus. Ill effects from the condition can include [...]
Well over two years into the pandemic, hundreds of thousands of COVID cases continue to be recorded around the world every day. With the rise of new variants, the symptoms of COVID have also evolved. Initially, [...]
Drug resistance is a common phenomenon, with drugs becoming less and less effective as their usage increases. To address this issue, a novel technique employing conjugated polymer-based nanoparticles is presented in the study published [...]
Microrobots have the potential to revolutionize medicine. Researchers at the Max Planck ETH Centre for Learning Systems have now developed an imaging technique that for the first time recognises cell-sized microrobots individually and at [...]
Scientists have recently developed multifunctional hexagonal NaxWO3 nanocrystals that can serve as microwave sensitizers to kill cancer cells as well as improve the overall chemodynamic therapy (CDT). This study is available as a pre-proof in Chemical Engineering Journal. [...]
Apple’s visionary founder, the late Steve Jobs once said, “the biggest innovations of the 21st century will be at the intersection of biology and technology”. And that prediction is coming true in the drug [...]
Chemical separation processes are essential in the manufacturing of many products from gasoline to whiskey. Such processes are energetically costly, accounting for approximately 10–15 percent of global energy consumption. In particular, the use of [...]
Scientists have recently developed electrochemical immunosensors based on graphene oxide−gold (GO−Au) nanocomposites. These immunosensors are highly sensitive with dual function, i.e., they can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen and antibody. [...]